Ersilia is a nonprofit enterprise focused on democratizing machine learning for biomedical research in infectious and neglected tropical diseases. The company aims to provide the community with a set of computational tools related to global health drug discovery, with a goal of lowering the barrier to the development of new medicines through open-source drug discovery. Founded in 2020, Ersilia builds and deploys thousands of predictive models related to target profiling, drug repurposing, and safety, with a special emphasis on neglected tropical diseases. Operating in the Health Care industry, Ersilia is poised to make significant contributions to the field of biomedical research and drug development.
General Information
BounceWatch is an independent company data service, not affiliated with Ersilia. To contact Ersilia, visit ersilia.io.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Spain Market
Health Care
About Ersilia
Taxonomy: machine learning models, biomedical research, open-source drug discovery, predictive modeling, drug repurposing, target profiling, global health, neglected tropical diseases, computational tools, nonprofit enterprise, community empowerment
No funding data available for Ersilia yet.
Ersilia Alternatives & Competitors
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...
On a quest to leverage the power of single cell genomics to discover novel drug targets and precisio...
AI-powered tissue analysis, validated by pathologists
FAQ About Ersilia
Source: BounceWatch company record for Ersilia, https://bouncewatch.com/company/ersilia, updated 14 November 2024. When citing, please name BounceWatch and link this page.